You are here: Home » PTI Stories » National » News
Business Standard

AI system can predict treatment effectiveness

Topics
Health Medical Pharma

Press Trust of India  |  London 

Scientists have developed a new artificial intelligence (AI) technology that can compare different treatments and identify the most suitable alternative for a patient.

Traditionally, the effectiveness of medical treatments is studied by randomised trials where patients are randomly divided into two groups: one of the groups is given treatment, and the other a placebo.

Scientists including those from Aalto University and University of Eastern Finland showed that there may be other ways to evaluate treatment effectiveness.

According to Professor Olli-Pekka Ryynanen from the University of Eastern Finland, the method opens up new and significant avenues for the development of medical research.

"We can now predict the treatment outcome in individual patients and to evaluate existing and new treatment methods. With this method, it is also possible to replace some randomised trials with modelling," said Ryynanen.

In the study published in the journal Healthcare Informatics Research, the researchers used the method to evaluate treatment effectiveness in obstructive sleep apnoea.

However, the method can also be applied to other treatments, researchers said.

The study showed that in patients with sleep apnoea, the continuous positive airway pressure (CPAP) treatment reduced mortality and the occurrence of myocardial infarctions and cerebrovascular insults by five percent in the long term.

For patients with heart conditions, CPAP was less beneficial.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sun, November 18 2018. 17:55 IST
RECOMMENDED FOR YOU